Reducing Sugar-sweetened Beverage Consumption Among Young Adults
NCT ID: NCT03672578
Last Updated: 2019-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2971 participants
INTERVENTIONAL
2018-08-18
2018-11-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Study of the Effects of Sugary Drink Warning Labels on Consumption
NCT05079477
Beverages and Societal Health
NCT01295671
Impact of Sugar-Sweetened Beverage Health Warnings
NCT03511937
Effects of Sugary Drink Warning Labels on Parent Choices
NCT04259385
Are Sugar-Sweetened Beverage Information Labels Well-Targeted
NCT05038163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Loss-frame, text-only, no attribution
Label participants will see is loss-frame, text-only, and with no attribution
loss-frame
loss frame label
text-only
text-only label
no attribution
label with no attribution
Gain-frame, text-only, no attribution
Label participants will see is gain-frame, text-only, and with no attribution
gain-frame
gain frame label
text-only
text-only label
no attribution
label with no attribution
Loss-frame, icon, no attribution
Label participants will see is loss-frame, icon, and with no attribution
loss-frame
loss frame label
icon
label with icon and text
no attribution
label with no attribution
Grain-frame, icon, no attribution
Label participants will see is gain-frame, with an icon, and with no attribution
gain-frame
gain frame label
icon
label with icon and text
no attribution
label with no attribution
Loss-frame, icon, attribution
Label participants will see is loss-frame, icon, and with attribution
loss-frame
loss frame label
icon
label with icon and text
attribution
label with attribution
Gain-frame, icon, attribution
Label participants will see is grain-frame, icon, and with attribution
gain-frame
gain frame label
icon
label with icon and text
attribution
label with attribution
Loss-frame, text-only, attribution
Label participants will see is loss-frame, text-only, and with attribution
loss-frame
loss frame label
text-only
text-only label
attribution
label with attribution
Gain-frame, text-only, attribution
Label participants will see is gain-frame, text-only, and with attribution
gain-frame
gain frame label
text-only
text-only label
attribution
label with attribution
No label
Participant will not see a label
No label
No label
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
loss-frame
loss frame label
gain-frame
gain frame label
text-only
text-only label
icon
label with icon and text
attribution
label with attribution
no attribution
label with no attribution
No label
No label
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current/recent (\<1 year of graduation) undergraduate student at 3 specific universities
* English-speaking
* consumes at least 2 SSBs per week
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Falbe, ScD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Davis
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1124060
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.